Rethinking Version Control in Clinical Research: Why Git is the Future
- Trinath Panda
- 5 days ago
- 3 min read
Updated: 3 days ago
Introduction
Just imagine you’re working on a SDTM dataset, and after multiple rounds of changes/updates, you realize that an earlier version had the correct mapping of variables. Now you’re scrambling through limitless file versions named "final_v1", "final_v3" and "final_v4". If this sounds familiar to you then, you’re not alone.
Version control is critical in the clinical research industry, ensuring transparency, reproducibility, and collaboration. While many industries have moved to Git-based version control, clinical statistical programming still relies on traditional methods like shared drives or enterprise cloud storage.
But times are changing now—Git is slowly making its way into the pharmaceutical industry, offering a structured and automated way to manage code (SAS, R, Python), datasets (SDTM, ADaM, TLFs), and quality control (QC) processes.
How Version Control is Currently Managed in the Industry
Some of the common approaches include:
Shared drives like onedrive: Programmers store their scripts, SDTM/ADaM datasets, and TLFs in folders, manually updating the version numbers as per their companies.
Enterprise cloud platform: Companies use different platforms like Microsoft SharePoint or custom-built pharma tools for managing controlled documents.
(CVS) Concurrent version control systems: Some pharma companies have built their proprietary tools for versioning, often running on backend systems like Subversion (SVN), Tortoise CVS or Perforce.
Use of Git: A growing number of teams are now adopting Git-based platforms like GitHub, GitLab, or Bitbucket to manage R, Python, and SAS scripts in clinical programming.
Why Git? Let’s Break It Down
Git isn’t just for Silicon Valley coders. Here’s how it solves real problems for clinical programmers:
No More "Final_Final" Files Git logs every change to your SAS/R/Python scripts automatically. Each update gets a timestamp, author name, and commit message like "Fixed AE severity mapping in SDTM domain."
Collaborate Without Chaos Multiple programmers editing the same ADaM script? Git lets you:
Work in parallel using branches (e.g., "JK_AE_Updates" or "TLF_QC_Branch").
Merge changes safely with pull requests, so no one overwrites your work.
Roll Back Mistakes Instantly Found an error in your SDTM dataset? Revert to yesterday’s version with one command. No more digging through backups!
Audit Trails Made Easy Git’s built-in history satisfies regulators by answering:
Who changed the code?
What did they change?
When was it done?
Why? (Thanks to descriptive commit messages!)
But Wait—There Are Hurdles
Adopting Git isn’t all rainbows and unicorns. Here’s what teams struggle with:
🚧 "Git Feels Like Learning Mandarin!"
Fix: Start small. Use GitHub Desktop (no command line needed!) and train teams with pharma-specific tutorials.
🚧 "Our Datasets Are Too Big!"
Fix: Use Git for code/scripts and pair it with Git LFS (Large File Storage) or secure cloud storage for datasets.
🚧 "Will Regulators Approve This?"
Good news: Git aligns with 21 CFR Part 11 if configured properly (user authentication, audit trails).
Regulatory Perspectives on Version Control
Regulators like the FDA and EMA emphasize data integrity, transparency, and traceability. While they don’t mandate the use of Git, its features align well with regulatory expectations:
21 CFR Part 11 Compliance: Git provides electronic records with timestamps and user authentication.
Audit readiness: A complete history of dataset transformations supports regulatory audits.
Validation and change control: Git enhances validation by tracking every modification in programming scripts.
The Future of Version Control in Pharma
The industry is shifting—slowly but surely. Trends to watch:
Pharma-First Git Tools: Platforms tailored for clinical programmers (think: built-in CDISC checks).
Dataset Versioning Solutions: Improved solutions for versioning large files in regulated environments.
Regulatory Embrace: EMA/FDA guidance acknowledging Git as a compliant tool.
So… Should Your Team Switch to Git?
If you’re drowning in "Final_v10" files or scrambling during audits, yes. Start with pilot projects like SDTM mapping or TLF scripts. The learning curve stings at first, but the payoff—sanity, speed, and compliance—is worth it.
What’s your take?
Still using shared drives?
Already experimenting with Git?
Have a horror story about version control gone wrong?
Drop a comment below—let’s commiserate (and collaborate)!
Comments